Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)
Clinical trial NCT02203149 · COMPLETED
Trial details
- NCT number
- NCT02203149
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-10-02
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.